Yamaoka Masakazu, Deguchi Miki, Ninomiya Kiichiro, Kurasako Toshiaki, Matsumoto Mutsuko
Department of Anesthesiology, Japanese Red Cross Society Himeji Hospital, 1-12-1, Shimoteno, Himeji, Japan.
Department of Allergy and Respiratory Medicine, Okayama University Hospital, Okayama, Japan.
J Anesth. 2017 Feb;31(1):148-151. doi: 10.1007/s00540-016-2280-4. Epub 2016 Nov 16.
An anaphylactic reaction during a cesarean section occurs rarely, and rocuronium is thought to be one of the common agents causing perioperative anaphylaxis. Here we report an anaphylactic shock after cesarean section that is suggested to be induced by the rocuronium-sugammadex complex. A 36-year-old primigravida underwent an elective cesarean section under general anesthesia due to placenta previa. While the operation was completed uneventfully, she developed anaphylactic shock following sugammadex administration. She was successfully managed with rapid treatments. Serum tryptase level was significantly elevated. Although sugammadex was first suspected to be the causative agent, the result of intradermal skin tests with sugammadex were negative. Surprisingly, a subsequent intradermal test with undiluted rocuronium caused the patient to fall into a state of shock. Furthermore, a later skin-prick test with pre-mixed rocuronium-sugammadex complex also revealed a strong positive reaction, and a test with only rocuronium showed negative. We finally concluded that the rocuronium-sugammadex complex is the causative agent in this case. To the best of our knowledge, this is the first report suggesting anaphylaxis caused by the rocuronium-sugammadex complex. This case highlights the importance of appropriate examinations to determinate the pathogenesis of anaphylaxis in order to establish risk reduction strategies.
剖宫产术中发生过敏反应的情况很少见,罗库溴铵被认为是围手术期过敏反应的常见诱因之一。在此,我们报告一例剖宫产术后过敏性休克,提示由罗库溴铵 - 舒更葡糖复合物引起。一名36岁初产妇因前置胎盘在全身麻醉下行择期剖宫产术。手术顺利完成,但在给予舒更葡糖后她发生了过敏性休克。经快速治疗,她成功脱险。血清类胰蛋白酶水平显著升高。虽然最初怀疑舒更葡糖是致病因素,但舒更葡糖皮内试验结果为阴性。令人惊讶的是,随后用未稀释的罗库溴铵进行皮内试验导致患者陷入休克状态。此外,随后对预混合的罗库溴铵 - 舒更葡糖复合物进行的皮肤点刺试验也显示出强烈的阳性反应,而仅用罗库溴铵进行的试验为阴性。我们最终得出结论,罗库溴铵 - 舒更葡糖复合物是该病例的致病因素。据我们所知,这是第一例提示由罗库溴铵 - 舒更葡糖复合物引起过敏反应的报告。该病例凸显了进行适当检查以确定过敏反应发病机制从而制定风险降低策略的重要性。